| 翻訳と辞書 |
Parve101q
ParvE101Q is an experimental modification of parvalbumin, designed to delay calcium sequestration in heart muscles to enhance contraction. The protein parvalbumin has EF hand motifs used for calcium binding. EF hands are structural helix-loop-helix protein subunits that have a high affinity for calcium ions, and a moderate affinity for magnesium ions. In muscle, the binding of Ca2+ by parvalbumin efficiently sequesters it following contraction. This increases the speed of muscle relaxation, allowing the muscle to contract again sooner.〔 Although parvalbumin is classified as a delayed calcium buffer, it quickly sequesters Ca2+, usually before the muscle is done fully contracting. Large amounts of parvalbumin allow rapid contractions of muscles at a high contractile speed with the trade-off of having relatively lower contraction force.〔 This decreased force of contraction is due to the rapid sequestration of Ca2+, preventing prolonged contraction which is required for greater force.
== Biochemistry ==
It has been theorized that expressing a modified version of parvalbumin in the heart could have therapeutic use to aid heart contraction, and treat relaxation disorders. ParvE101Q is optimized so that relaxation is rapid, but contraction lasts for a sufficient time to fully eject blood.〔 Amino acid substitutions of glutamine for glutamate on the protein’s 101st amino acid were introduced, followed immediately by a tryptophan replacing a phenylalanine at site 102, as well as alanine replacing aspartate at site 51. By introducing these changes, the preferential binding of Ca2+ and Mg2+ were reversed. Instead of having high preference for Ca2+ like parvalbumin, ParvE101Q has a preference for Mg2+ first, and Ca2+ second.〔 This reversed binding preference allows the normal presence of Mg2+ to delay the Ca2+ sequestration of ParvE101Q. This delay allows heart contraction to last long enough to preserve blood ejection, then have the excess Ca2+ bound and sequestered by ParvE101Q. The resulting increase in contractility is speculated to be due to the increased Mg2+ binding affinity. By binding Mg2+ first, ParvE101Q allows more Ca2+ binding to Troponin C, which is required for myocyte contraction.〔 The result of the modification is an increased contractility and quicker relaxation in myocytes with no reported side-effects.〔 This modified protein retains the heart’s ability to store calcium in the sarcoplasmic reticulum, even under the added stress of caffeine. Additionally, when treated with ParvE101Q, calcium sparks (spontaneous releases of Ca2+ from the sarcoplasmic reticulum) are not different from normal. Other Ca2+ handling proteins used for sequestration are not affected by ParvE101Q, and the effects are not dependent on temperature changes.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Parve101q」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|